Skip to Content

Join the 'Corticotropin' group to help and get support from people like you.

Corticotropin News

FDA Approves H.P. Acthar Gel for the Treatment of Infantile Spasms

Posted 18 Oct 2010 by

ANAHEIM, Calif., Oct. 15 /PRNewswire-FirstCall/ – Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children ...

Ask a Question

Further Information

Related Condition Support Groups

Ankylosing Spondylitis, Psoriatic Arthritis, Allergies, Uveitis, Ulcerative Colitis, Systemic Lupus Erythematosus, Stevens-Johnson Syndrome, Serum Sickness, Sarcoidosis, view more... Rheumatoid Arthritis, Psoriasis, Polymyositis / Dermatomyositis, Multiple Sclerosis, Optic Neuritis, Keratitis, Juvenile Rheumatoid Arthritis, Iritis, Iridocyclitis, Inflammatory Bowel Disease, Focal Segmental Glomerulosclerosis, Eye Conditions, Erythema Mulitforme, Chorioretinitis, Chorioditis, West Syndrome

Related Drug Support Groups

Acthar, Acthar Gel, HP, Acth, Acth Gel, Acth-40 HP, Acth-80

Corticotropin Patient Information at